company background image
301257 logo

SMO ClinPlusLTD SZSE:301257 Stock Report

Last Price

CN¥43.29

Market Cap

CN¥2.6b

7D

-3.1%

1Y

-34.7%

Updated

24 Apr, 2024

Data

Company Financials

SMO ClinPlus CO.,LTD.

SZSE:301257 Stock Report

Market Cap: CN¥2.6b

301257 Stock Overview

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.

301257 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 301257 from our risk checks.

SMO ClinPlus CO.,LTD. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SMO ClinPlusLTD
Historical stock prices
Current Share PriceCN¥43.29
52 Week HighCN¥85.61
52 Week LowCN¥33.60
Beta0
1 Month Change-14.24%
3 Month Change-16.91%
1 Year Change-34.72%
3 Year Changen/a
5 Year Changen/a
Change since IPO-42.00%

Recent News & Updates

Recent updates

Shareholder Returns

301257CN Life SciencesCN Market
7D-3.1%2.2%1.6%
1Y-34.7%-38.3%-15.1%

Return vs Industry: 301257 exceeded the CN Life Sciences industry which returned -38.3% over the past year.

Return vs Market: 301257 underperformed the CN Market which returned -15.1% over the past year.

Price Volatility

Is 301257's price volatile compared to industry and market?
301257 volatility
301257 Average Weekly Movement10.0%
Life Sciences Industry Average Movement9.6%
Market Average Movement8.8%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.3%

Stable Share Price: 301257's share price has been volatile over the past 3 months.

Volatility Over Time: 301257's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20094,061n/awww.smo-clinplus.com

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company’s SMO services incudes preliminary model establishment, preliminary plan preparation, initiation of clinical trial sites, on-site implementation, and project management services.

SMO ClinPlus CO.,LTD. Fundamentals Summary

How do SMO ClinPlusLTD's earnings and revenue compare to its market cap?
301257 fundamental statistics
Market capCN¥2.65b
Earnings (TTM)CN¥135.11m
Revenue (TTM)CN¥728.80m

19.6x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301257 income statement (TTM)
RevenueCN¥728.80m
Cost of RevenueCN¥502.73m
Gross ProfitCN¥226.07m
Other ExpensesCN¥90.96m
EarningsCN¥135.11m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 29, 2024

Earnings per share (EPS)2.21
Gross Margin31.02%
Net Profit Margin18.54%
Debt/Equity Ratio0.3%

How did 301257 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

8%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.